In this article the authors hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with COVID-19.

In this open-label, adaptive, multiplatform, randomized clinical trial, critically ill COVID-19 patients were randomly assigned to a regimen of either therapeutic-dose anticoagulation with heparin or pharmacologic thromboprophylaxis in accordance with local usual care.

In this trial, the authors assigned COVID-19 patients to receive either one unit of convalescent plasma with a high titer of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a placebo.

Observational study: prospective longitudinal cohort (Green) Authors: Carl H Göbel, Axel Heinze, Sarah Karstedt, Mascha Morscheck, Lilian Tashiro, Anna Cirkel, Qutayba Hamid, Rabih Halwani, Mohamad-Hani Temsah, Malte Ziemann, Siegfried Görg, Thomas Münte, Hartmut Göbel The novel coronavirus SARS-CoV-2 causes the… Continue Reading

The EAN Mentorship programme was launched during the Virtual Congress in June 2021

Read latest clinical fellowship reports from 2021!

Launched during the virtual congress in June 2021, EAN would like to foster interest and connection to the very early career medical students who are still considering whether they want to proceed into the field of neurology, or to those who have already found their way to neurology but are still a bit unsure to which sub-specialty their journey might lead them.

How would you describe the mission of the RRFS if you were explaining it to a member of the public? The Resident and Research Fellow Section is the young section of the European Academy of Neurology. The major aim is… Continue Reading

EAN Scientific Committee Chair, Thomas Berger, gives early notice of the upcoming elections for Scientific Panel Management Groups and an update on recent scientific activities.

For September 2021, we have selected: Ramsden CE et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial

For September 2021, we have selected: ''Aschman A et al. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died'' and ''Suh J et al. Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19''

The application deadline for the 2022 EAN Research Fellowships is 31.08.2021

Prof. Elena Lebedeva, member of the EAN Task Force on Gender and Diversity Issues in Neurology, interviews Prof. David Dodick, Professor of Neurology, Director of the Headache and Concussion Programs at Mayo Clinic in Arizona.

The European Academy of Neurology Board and Education Committee are pleased to announce the addition of four new e-Learning Associate Editors to the e-Learning Editorial Board. Together with Editor-in-Chief, Prof. Barbara Tettenborn, and the eLearning sub-committee, they will shape the future of EAN e-Learning activities.

The EAN-Day in Greece took place on 2 June, 2021, organised under the auspices of the EAN, the Hellenic Neurological Society and Professor Nikolaos Grigoriadis, the Head of the Hellenic Neurological Society.